TY - JOUR
T1 - Localized Changes in Dentate Nucleus Shape and Magnetic Susceptibility in Friedreich Ataxia
AU - Harding, Ian H.
AU - Nur Karim, Muhammad Ikhsan
AU - Selvadurai, Louisa P.
AU - Corben, Louise A.
AU - Delatycki, Martin B.
AU - Monti, Serena
AU - Saccà, Francesco
AU - Georgiou-Karistianis, Nellie
AU - Cocozza, Sirio
AU - Egan, Gary F.
N1 - Funding Information:
: Australian National Health and Medical Research Council (NHMRC: Fellowship 1106533, Ideas Grant 1184403, and Project Grant 1046037), the Friedreich Ataxia Research Alliance (USA), and the Friedreich Ataxia Research Association (Australia). Funding agencies
Funding Information:
I.H.H. reports grant funding from the Australian National Health and Medical Research Council, Medical Research Future Fund, Friedreich Ataxia Research Alliance, National Ataxia Foundation, Telethon Fondazione; and consultancies with Steminent Biotherapeutics and PTC Therapeutics. M.I.N.K. has no financial disclosures. L.P.S. has no financial disclosures. L.A.C. reports grant funding from Friedreich's Ataxia Research Alliance, Ataxia UK, and Medical Research Futures Fund. M.B.D. reports grants from the Australian National Health and Medical Research Council, Medical Research Future Fund, and Friedreich Ataxia Research Alliance. S.M. reports grant funding from the Italian Ministry of University and Research. N.G.K. reports grants from the Friedreich Ataxia Research Alliance. S.C. reports grand funding from the Fondazione Telethon and fees for the Advisory Board from Amicus Therapeutics. G.F.E. reports patents unrelated to this work (PCT/AU2019/0505447, PCT/AU2019/050448).
Funding Information:
We thank the study participants for their contribution to this work. This work was supported by the Australian National Health and Medical Research Council (NHMRC: Fellowship 1106533, Ideas Grant 1184403, and Project Grant 1046037), the Friedreich Ataxia Research Alliance (USA), and the Friedreich Ataxia Research Association (Australia). Open access publishing facilitated by Monash University, as part of the Wiley \u2010 Monash University agreement via the Council of Australian University Librarians.
Publisher Copyright:
© 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
PY - 2024/7
Y1 - 2024/7
N2 - Background: The dentate nuclei of the cerebellum are key sites of neuropathology in Friedreich ataxia (FRDA). Reduced dentate nucleus volume and increased mean magnetic susceptibility, a proxy of iron concentration, have been reported by magnetic resonance imaging studies in people with FRDA. Here, we investigate whether these changes are regionally heterogeneous. Methods: Quantitative susceptibility mapping data were acquired from 49 people with FRDA and 46 healthy controls. The dentate nuclei were manually segmented and analyzed using three dimensional vertex-based shape modeling and voxel-based assessments to identify regional changes in morphometry and susceptibility, respectively. Results: Individuals with FRDA, relative to healthy controls, showed significant bilateral surface contraction most strongly at the rostral and caudal boundaries of the dentate nuclei. The magnitude of this surface contraction correlated with disease duration, and to a lesser extent, ataxia severity. Significantly greater susceptibility was also evident in the FRDA cohort relative to controls, but was instead localized to bilateral dorsomedial areas, and also correlated with disease duration and ataxia severity. Conclusions: Changes in the structure of the dentate nuclei in FRDA are not spatially uniform. Atrophy is greatest in areas with high gray matter density, whereas increases in susceptibility—reflecting iron concentration, demyelination, and/or gliosis—predominate in the medial white matter. These findings converge with established histological reports and indicate that regional measures of dentate nucleus substructure are more sensitive measures of disease expression than full-structure averages. Biomarker development and therapeutic strategies that directly target the dentate nuclei, such as gene therapies, may be optimized by targeting these areas of maximal pathology.
AB - Background: The dentate nuclei of the cerebellum are key sites of neuropathology in Friedreich ataxia (FRDA). Reduced dentate nucleus volume and increased mean magnetic susceptibility, a proxy of iron concentration, have been reported by magnetic resonance imaging studies in people with FRDA. Here, we investigate whether these changes are regionally heterogeneous. Methods: Quantitative susceptibility mapping data were acquired from 49 people with FRDA and 46 healthy controls. The dentate nuclei were manually segmented and analyzed using three dimensional vertex-based shape modeling and voxel-based assessments to identify regional changes in morphometry and susceptibility, respectively. Results: Individuals with FRDA, relative to healthy controls, showed significant bilateral surface contraction most strongly at the rostral and caudal boundaries of the dentate nuclei. The magnitude of this surface contraction correlated with disease duration, and to a lesser extent, ataxia severity. Significantly greater susceptibility was also evident in the FRDA cohort relative to controls, but was instead localized to bilateral dorsomedial areas, and also correlated with disease duration and ataxia severity. Conclusions: Changes in the structure of the dentate nuclei in FRDA are not spatially uniform. Atrophy is greatest in areas with high gray matter density, whereas increases in susceptibility—reflecting iron concentration, demyelination, and/or gliosis—predominate in the medial white matter. These findings converge with established histological reports and indicate that regional measures of dentate nucleus substructure are more sensitive measures of disease expression than full-structure averages. Biomarker development and therapeutic strategies that directly target the dentate nuclei, such as gene therapies, may be optimized by targeting these areas of maximal pathology.
KW - biomarker
KW - cerebellum
KW - magnetic resonance imaging
UR - http://www.scopus.com/inward/record.url?scp=85191171945&partnerID=8YFLogxK
U2 - 10.1002/mds.29816
DO - 10.1002/mds.29816
M3 - Article
C2 - 38644761
AN - SCOPUS:85191171945
SN - 0885-3185
VL - 39
SP - 1109
EP - 1118
JO - Movement Disorders
JF - Movement Disorders
IS - 7
ER -